Role of gp91phox in hepatic macrophage programming and alcoholic liver disease
Meng Wang1, S Courtney Frasch2, Guiying Li3
1Skaggs School of Pharmacy and Pharmaceutical Sciences University of Colorado Anschutz Medical Campus Aurora CO.
Abstract:
Hepatic macrophages (MΦs) are important in the development and progression of alcoholic liver disease (ALD). This study investigates the role of gp91phox (nicotinamide adenine dinucleotide phosphate oxidase 2) in the severity of ALD and specifically in regulating hepatic MΦ efferocytic capability and the subsequent reprogramming associated with resolution of inflammation. After 4 weeks of ethanol feeding, more severe ALD developed in gp91phox-/- mice than in wild-type (WT) C57Bl/6J mice, evidenced by increased liver injury and inflammation. This phenomenon was not sex dependent, and thus the majority of experiments were performed with female mice. While total hepatic MΦ numbers did not differ between genotypes, hepatic infiltrating MΦs (IMs) were slightly more numerous in gp91phox-/- mice, and both IMs and resident Kupffer cells displayed enhanced proinflammatory and reduced tissue-restorative programming compared with these cells from WT mice. The ratio of proinflammatory IMs with higher expression of Ly6C (Ly6Chi) to anti-inflammatory IMs with lower expression of Ly6C (Ly6Clow) was significantly higher in gp91phox-/- mice compared to WT mice. Greater numbers of apoptotic cells accumulated in the liver of gp91phox-/- mice compared to WT mice, and receptors for binding and engulfing apoptotic cells were expressed at much lower levels on both Kupffer cells and IMs of gp91phox-/- mice. Interactions with apoptotic cells (binding and engulfment) in vitro were significantly fewer for gp91phox-/- MΦs than for WT MΦs, resulting in diminished expression of tissue restorative mediators by hepatic MΦs of gp91phox-/- mice. Conclusion: gp91phox plays a critical role in the differentiation of proinflammatory hepatic MΦs to a tissue-restorative phenotype, likely through programming for efferocytosis, and thereby lessens the severity of ALD. These findings enhance our understanding of the tissue environmental cues that regulate MΦ phenotypes. This knowledge could help in designing MΦ-targeting strategies to prevent and treat ALD. (Hepatology Communications 2017;1:765-779).
Insights
gp91phox deficiency worsens alcoholic liver disease by impairing hepatic macrophage efferocytosis. This leads to increased inflammation and liver injury, highlighting gp91phox's role in resolving liver damage.
Area of Science:
- Hepatology
- Immunology
- Cell Biology
Background:
- Hepatic macrophages (MΦs) are crucial in alcoholic liver disease (ALD) progression.
- gp91phox (NADPH oxidase 2) role in MΦ function and ALD severity is unclear.
Purpose of the Study:
- Investigate gp91phox's impact on ALD severity.
- Determine its role in hepatic MΦ efferocytosis and inflammation resolution.
Main Methods:
- Utilized gp91phox-/- and wild-type (WT) mice fed ethanol for 4 weeks.
- Assessed liver injury, inflammation, MΦ phenotype, and efferocytic capacity.
- Conducted in vitro MΦ-apoptotic cell interaction studies.
Main Results:
- gp91phox-/- mice exhibited more severe ALD, increased liver injury, and inflammation.
- Hepatic MΦs in gp91phox-/- mice showed enhanced proinflammatory and reduced tissue-restorative programming.
- Impaired efferocytosis and lower expression of efferocytosis receptors were observed in gp91phox-/- MΦs.
Conclusions:
- gp91phox is critical for hepatic MΦ efferocytosis and resolution of inflammation in ALD.
- gp91phox deficiency promotes a proinflammatory MΦ phenotype, exacerbating liver disease.
- Targeting gp91phox may offer therapeutic strategies for ALD.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatic Drug Clearance: Role of Transporters
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug


